Data from pivotal Phase 3 trial in CHB-associated liver fibrosis expected in Q2 2025Commercial launch in the PRC of generic nintedanib for the ...
Chennai: For nearly six weeks, a flurry of bureaucratic activity has gripped the secretariat, with files shuttling between departments and legal exper.